Shutterstock 545031478 (1)

Product Opportunity Evaluation and Maximisation

We can help your business to:

  • Scan the landscape of opportunities - as asset owners or investors
  • Plan a path to market for assets in early development
  • Assess commercial viability and valuation of assets
  • Undertake effective due diligence on assets and data

For assets in the preclinical to Phase 2 space evaluating the opportunity and planning the best development path to patient and market becomes a priority. The VPA POEM group can help to maximise the value of assets by providing an integrated view of the therapeutic area landscape, the competition, the development options and challenges, the regulatory path, and commercial considerations and risks. Additionally for those looking to acquire or license assets we can provide Due Diligence services with full valuation, deal terms, and legal and IP guidance.

Meet our practice leads